Although the evidence led us to investigate a strategy for modulation or prevention of NIDDM with obesity-related glucose tolerance by adiponectin-like food compounds, no alternative-medicinal food studies regarding an adiponectin-like “orally active” natural agonist have been reported so far. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.